158 filings
Page 4 of 8
8-K
92ait
5 May 22
Keros Therapeutics Reports First Quarter 2022 Financial Results
8:04am
DEFA14A
v2i cp4d9s
18 Apr 22
Additional proxy soliciting materials
4:02pm
S-8
ir2d6u8 flv0
9 Mar 22
Registration of securities for employees
4:27pm
8-K
0yfph3xg0j o08e
9 Mar 22
March 2022 Corporate Presentation
4:17pm
8-K
i2hkvtpozwr10ozcmh
9 Mar 22
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financial Results
4:02pm
8-K
6dtjtz2an3i i1j
11 Feb 22
Keros Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
8:02am
8-K
7bzqb3hqs m6mkmf
31 Jan 22
Keros Therapeutics Appoints Christopher Rovaldi as Chief Operating Officer
8:02am
8-K/A
e8g1jddksqz6a
13 Dec 21
Other Events
4:07pm
8-K
vxmdo
13 Dec 21
Other Events
9:04am
8-K
pzsz18z3ywq2 5occ7
13 Dec 21
Keros Therapeutics Announces Licensing Agreement and Strategic Partnership with Hansoh Pharma for Rights to KER-050 in China
8:02am
8-K
hc8pbqwt8 ax4
22 Nov 21
Keros Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
8:03am
8-K
t7twjm3k3m089wul2rh
15 Nov 21
Keros Therapeutics Presents Results from a Preclinical Study of RKER-012 at the American Heart Association 2021 Scientific Sessions
8:04am
8-K
tub6ji
12 Nov 21
Keros Therapeutics to Present at the Jefferies Virtual London Healthcare Conference
8:05am
8-K
fv1gr
4 Nov 21
November 2021 Corporate Presentation
9:24am
8-K
7enamr3femuif75
4 Nov 21
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2021 Financial Results
9:04am
8-K
g6bfk2gs01
4 Oct 21
Other Events
8:02am